Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b57587f1126c6b15721dcd24d722a99 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df74c5bfff0d8e1d3711a32b257d65b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b95f704a59a954b143f241ebe6a8275 |
publicationDate |
2011-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2278967-A1 |
titleOfInvention |
Bis-quaternary pyridinium-aldoyime salts and treatment of exposure to cholinesterase inhibitors |
abstract |
Bis-quaternary pyridinium-aldoxime salts are disclosed, and their associated polymorphic character, along with their methods of preparation. Such polymorphic salts may then be used for treatment of exposure to cholinesterase inhibitors, such as a phosphorous containing cholinesterase inhibitor type compound. |
priorityDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |